[Immunocytochemical phenotyping of centroblastic lymphoma cells].
Using immunocytochemical phenotyping, the authors assessed the origin of malignant cells in a patient with malignant centroblastic lymphoma. The lymphoma cells expressed the thymocytic surface molecule CD1, pan T-lymphocytic markers CD2, CD5, CD6, CD7 with concurrent absence of complex CD3 and receptors for antigen on T lymphocytes. The proliferating activity of malignant cells could not be controlled by intensive cytostatic therapy.
Krejsek
J
J
II. interní klinika LF UK, Hradec Králové.
Kopecký
O
O
Zák
P
P
Podzimek
K
K
D000293:Adolescent; D006801:Humans; D016130:Immunophenotyping; D016399:Lymphoma, T-Cell / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000473:pathology
Imunocytochemická fenotypizace bunĕk centroblastického lymfomu.